Chondrosarcomas Completed Phase 1 Trials for Tanespimycin (DB05134)

Also known as: Chondrosarcoma / Chondroma sarcomatosum / Chondrosarcoma NOS / [M]Chondrosarcoma NOS

IndicationStatusPhase
DBCOND0036125 (Chondrosarcomas)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0000424117-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaTreatment